DermTopic: Psoriasis

Promius Pharma Launches Promiseb Topical Cream 60 Gram Option

Promius Pharma LLC launched Promiseb Topical Cream in a new 60-gram box. According to the company, Promiseb has demonstrated both anti-inflammatory and antifungal properties. …

Lack of Support Drives Psoriasis Patients to Social Media

Lack of support from family and friends drives psoriasis patients to use social media, a new study from the National Psoriasis Foundation (NPF) found. According to the finding…

Diagnosis and Management of Psoriatic exfoliative erythroderma

Clinical Solutions

Psoriatic exfoliative erythroderma is a very severe form of psoriasis that affects more than 75 percent of the body surface area (BSA) of a patient. Fortunately, it occurs in …

Treatment Approaches for Pregnant or Lactating Psoriasis Patients.

Clinical Solutions

Treating psoriasis patients who are either pregnant or lactating poses a number of challenges for clinicians. These stem from the fact that there are no clinical trials involv…

More Data Confirm Burden of Psoriasis

enews_091410

Psoriasis is a significant burden for patients and strongly impacts everyday life, new data show. (Journal of the European Academy of Dermatology & Venereology. 24: 9). Th…

C-reactive Protein Correlates with Psoriasis Severity

enews_2010-0707

C-reactive protein (CRP), the inflammatory marker associated with increased risk for heart disease, may be a suitable marker for psoriasis severity and the effects of treatmen…

Cyclosporine in Psoriasis Treatment

Clinical Solutions

Cyclosporine may be one of the best but least commonly utilized psoriasis treatments. Its onset of action and facility of usage helps many patients not only with acute exacerb…

Antibiotic Shows Promise in Psoriasis

enews2010-06-09

The antibiotic azithromycin appears to produce a durable response in psoriasis (Eur J Dermatol; 20(3):329-33). In a controlled trial lasting 48 weeks, 80 percent of subjects t…